Press release
Key Influencer in the Organoids And Spheroids Market 2025: Growing Demand for Cell Therapy and Tissue Engineering Fuels Organoids and Spheroids Market Expansion Driver
What Is the Forecasted Market Size and Growth Rate for the Organoids And Spheroids Market?In recent years, the market for organoids and spheroids has seen exceptional growth. It is projected to increase from $1.16 billion in 2024 to $1.45 billion in 2025, with a compound annual growth rate (CAGR) of 24.6%. This significant growth during the historic period can be linked to the rapid advancements in stem cell research and 3d cell culture methodologies, increased financial support and investments, a rise in chronic illnesses, the growing utilization of organoids and spheroids in drug screening and toxicological studies, progress made in the field of regenerative medicine along with personalized medicine methods, and beneficial regulatory frameworks that favour the usage of advanced cell culture models for research.
The market size for organoids and spheroids is projected to experience significant expansion in the near future, expected to reach $3.46 billion by 2029 with a compound annual growth rate (CAGR) of 24.4%. The projected growth during this period is a result of ongoing advancements in technology, the burgeoning field of personalized medicine, growing implementations in cancer research, ethical and regulatory progress, an increase in commercial products and services that utilize organoid and spheroid technologies, and the furthering of education initiatives to train scientists in these technologies. Emerging trends during the forecast period encompass incorporating advanced technologies, the proliferation of high-throughput screening procedures using organoids for drug discovery, 3D bioprinting and bio fabrication, a rise in the application of organoids for various cancer models, and the integration of organoids with microfluidic systems.
What Factors Are Propelling the Expansion of the Organoids And Spheroids Market?
The growth of the organoids and spheroids market is predicted to be driven by the increasing demand for cell therapy and tissue engineering. These processes, which involve the use of living cells or curated tissues, are designed to replace, repair, or regenerate harmed tissues and organs within the body. As these methods have the potential to restore damaged tissues and cure previously untreatable conditions, they represent groundbreaking progress in the field of regenerative medicine. As a result of their efficacy in modelling intricate tissues and examining therapeutic strategies in vitro, organoids and spheroids are extensively used in cell therapy and tissue engineering. For example, as reported by Cell & Gene, a research resource based in the US, there were 27 FDA-approved cell and gene therapies (CGTs) in February 2023, comprising roughly 8% of the 340 approved biologics in 2022, up from 22 approved in 2021. It's expected that this growing demand for cell therapy and tissue engineering would significantly contribute to the expansion of the organoids and spheroids market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18421&type=smp
Which Businesses Are at the Forefront of Organoids And Spheroids Market Development?
Major companies operating in the organoids and spheroids market are Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, StemCell Technologies Canada Inc., Greiner Bio-One International AG, Promega Corporation, Molecular Devices LLC, American Type Culture Collection (ATCC), Mimetas B.V., InSphero AG, HUB Organoids, Emulate Inc., 3D Biomatrix Inc., Prellis Biologics Inc., 3D Biotek LLC, DefiniGEN Limited, Visikol Inc., Organovo Holdings Inc., Cellesce Ltd., AMS Biotechnology (Europe) Limited
What Are the Latest Innovations in the Organoids And Spheroids Market?
The primary players in the organoids and spheroids market are concentrating their efforts on bringing forth innovative solutions such as single-particle dispensers in a bid to enhance accuracy in cell handling and boost the repeatability of research findings. Single-particle dispensers are precision tools tailored to separate and dispense individual cells or particles, facilitating precise manipulation and control in both research and diagnostic undertakings. For example, SEED Biosciences, a biotech firm based in Switzerland, launched Dispen3D in July 2024. This innovative tool, which enables the accurate dispersal of individual organoids and spheroids, marks a remarkable advancement in the management of 3D cellular models. With this new dispenser, scientists are able to quickly and accurately shift single spheroids into multi-well plates, thereby automating the process and guaranteeing monoclonality essential for drug discovery and personalized therapy. Dispensing at low pressures, Dispen3D handles fragile cells delicately, preserving their structure and vitality. Its intuitive design makes it easily adaptable in different research settings, addressing the increasing demand for state-of-the-art tools in the life sciences.
How Is the Organoids And Spheroids Market Segmented?
The organoids and spheroids market covered in this report is segmented -
1) By Type: Organoids, Spheroids
2) By Method: Extracellular Matrix Scaffold Method, Spinning Bioreactor Method, Hanging Drop Method, Low Adherent Culture Plate Method, Magnetic levitation Method, Other Methods
3) By Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity And Efficacy Testing
4) By End User: Biotechnology And Pharmaceutical Industry, Academic And Research Institutes, Hospitals And Diagnostic Centers
Subsegments:
1) By Organoids: Intestinal Organoids, Liver Organoids, Brain Organoids, Kidney Organoids, Lung Organoids, Pancreatic Organoids, Cardiac Organoids, Retinal Organoids, Tumor Organoids, Organoids For Disease Modeling
2) By Spheroids: Cancer Spheroids, Neural Spheroids, Cardiac Spheroids, Liver Spheroids, Muscle Spheroids, Endothelial Spheroids, Stem Cell-Derived Spheroids, 3D Cell Culture Spheroids
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/organoids-and-spheroids-global-market-report
Where Is the Organoids And Spheroids Market Growth Most Prominent?
North America was the largest region in the organoids and spheroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoids and spheroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Organoids And Spheroids Global Market Report?
- Market Size Analysis: Analyze the Organoids And Spheroids Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Organoids And Spheroids Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Organoids And Spheroids Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Organoids And Spheroids Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18421
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Influencer in the Organoids And Spheroids Market 2025: Growing Demand for Cell Therapy and Tissue Engineering Fuels Organoids and Spheroids Market Expansion Driver here
News-ID: 3864183 • Views: …
More Releases from The Business Research Company

2025-2034 TCR Therapy Market Outlook: Key Drivers, Emerging Challenges, and Stra …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the TCR Therapy Industry Market Size Be by 2025?
The market size for TCR therapy has expanded rapidly in the past years. Projected to rise from $0.18 billion in 2024 to $0.26 billion in 2025, it will enjoy a compound annual growth rate (CAGR) of 39.3%. Elements…

2025 Preeclampsia Drugs Industry Trends Report: Long-Term Outlook Through 2034
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Preeclampsia Drugs Market Size By 2025?
The market size for drugs treating preeclampsia has seen robust growth in recent years. The market is expected to expand from $1.25 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%.…

Strategic Forecast for the Ovulation Inducing Drugs Industry: Market Outlook 202 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Ovulation Inducing Drugs Market Size Growth Forecast: What to Expect by 2025?
The market for ovulation stimulating medications has expanded significantly in the past years. The market, which was valued at $4.42 billion in 2024, is projected to increase to $4.7 billion in 2025, representing a compound annual growth…

Major Growth Driver Identified in 2025 Nicotine Replacement Therapy Market: Risi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Nicotine Replacement Therapy Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Strong growth has been observed in recent years in the nicotine replacement therapy market. The market size is projected to increase from $3.22 billion in 2024 to $3.44 billion in 2025, reflecting a compound…
More Releases for Organoids
Organoids: A Guide to Understanding the Process
Organoids are emerging as a powerful asset for researchers and drug developers as they seek more efficient and accurate methods to identify promising drug candidates and predict their efficacy. The ability to generate patient-derived organoids (PDOs) opens up exciting possibilities for personalized drug screening. Organoids serve as realistic and relevant models for drug screening compared to traditional 2D cell cultures. They mimic the complexity of human organs, including their cellular…
Patient-derived organoids open doors to personalized medicine
Recent advances in organoid technology have opened the possibility of revolutionizing basic research, drug discovery and development, and patient treatment.
Scientists are exploring the feasibility of using patient-derived organoids (PDOs) to develop and test personalized and regenerative medicine for certain cancer subtypes. Although this shows promise, broad adoption of organoids in drug discovery studies still faces many challenges, such as inconsistent quality, poor yield, slow data acquisition, and inaccurate data processing.
We…
Organoids Market Size, Insights, Analysis Report 2024-2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through Organoids Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The organoids market size has grown exponentially in recent years. It will grow…
Organoids Market - Pioneering Solutions for Personalized Medicine: Organoids Sha …
Newark, New Castle, USA - new report, titled Organoids Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Organoids market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Organoids market. The report offers an overview of the market, which briefly describes the…
Organoids and Spheroids Market Emerging Trends 2023-2030
The worldwide organoids and spheroids market size was estimated at USD 405.3 million in 2021 and is supposed to develop yearly from 2022 to 2028. Utilization of the organoids and spheroids models to uncover what the COVID-19 infection means for a few digestive cells is supposed to drive the reception of organoids in research. Researchers have been involving these frameworks for testing and recognizable proof of promising prescriptions. Organizations take…
Sweden Organoids Market Scrutinized in New Research 2030
Organoids Market: Introduction
According to the report, the global organoids market was valued over US$ 1.7 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030. Organoids are replicated or miniaturized versions of organs such as stomach, liver, lung, kidney, and brain produced from stems cells in vitro. These miniature models are three-dimensional tissue culture derived from stem cells. The stem cells are derived from pluripotent and…